Tolerogenic functions of human leukocyte antigen G: From pregnancy to organ and cell transplantation

Transplantation

Volumn 84, Issue 1 SUPPL., 2007, Pages

  Rouas Freiss, Nathalie ^a,c   Naji, Abderrahim ^a   Durrbach, Antoine ^b   Carosella, Edgardo D ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

^c Inst Univ d'Hématologie   (France)

Author keywords

Heart transplantation; HLA G; Kidney; Liver transplantation; Pregnancy; T cells

Indexed keywords

HLA G ANTIGEN;

ANTIGEN EXPRESSION; CELL TRANSPLANTATION; CONFERENCE PAPER; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; PREGNANCY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; CELL TRANSPLANTATION; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; ORGAN TRANSPLANTATION; PREGNANCY; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447562965     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269117.32179.1c     Document Type: Conference Paper

References (34)

1. Rouas-Freiss N, Goncalves RM, Menier C, et al. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997; 94: 11520.
2. Ponte M, Cantoni C, Biassoni R, et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A 1999; 96: 5674.
3. Lila N, Carpentier A, Amrein C, et al. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355: 2138.
4. Lila N, Amrein C, Guillemain R, et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002; 105: 1949.
5. Luque J, Torres MI, Aumente MD, et al. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 2006; 67: 257.
6. Qiu J, Terasaki PI, Miller J, et al. Soluble HLA-G expression and renal graft acceptance. Am J Transplant 2006; 6: 2152.
7. Creput C, Le Friec G, Bahri R, et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: Possible implications for monitoring patients. Hum Immunol 2003; 64: 1033.
8. Creput C, Durrbach A, Menier C, et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003; 39: 587.
9. Le Rond S, Le Maoult J, Creput C, et al. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: In vivo implications in transplanted patients. Eur J Immunol 2004; 34: 649.
10. Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997; 186: 1809.
11. Colonna M, Samaridis J, Cella M, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998; 160: 3096.
12. Shiroishi M, Tsumoto K, Amano K, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003; 100: 8856.
13. Rouas-Freiss N, Marchal RE, Kirszenbaum M, et al. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A 1997; 94: 5249.
14. Riteau B, Rouas-Freiss N, Menier C, et al. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001; 166: 5018.
15. Riteau B, Menier C, Khalil-Daher I, et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999; 43: 203.
16. + T cell regulatory mechanism. Proc Natl Acad Sci U S A 2001; 98: 12150.
17. Le Rond S, Azema C, Krawice-Radanne I, et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol 2006; 176: 3266.
18. Bahri R, Hirsch F, Josse A, et al. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 2006; 176: 1331.
19. Liang S, Baibakov B, Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 2002; 32: 2418.
20. LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. HLA-G upregulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. Faseb J 2005; 19: 662.
21. LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A 2004; 101: 7064.
22. Rouas-Freiss N, LeMaoult J, Moreau P, et al. HLA-G in transplantation: A relevant molecule for inhibition of graft rejection? Am J Transplant 2003; 3: 11.
23. LeMaoult J, Rouas-Freiss N, Carosella ED. Immuno-tolerogenic functions of HLA-G: Relevance in transplantation and oncology. Autoimmun Rev 2005; 4: 503.
24. Carosella ED, Moreau P, Le Maoult J, et al. HLA-G molecules: From maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003; 81: 199.
25. Fuzzi B, Rizzo R, Criscuoli L, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32: 311.
26. Sher G, Keskintepe L, Nouriani M, et al. Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency' and IVF outcome. Reprod Biomed Online 2004; 9: 74.
27. Noci I, Fuzzi B, Rizzo R, et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005; 20: 138.
28. Sher G, Keskintepe L, Batzofin J, et al. Influence of early ICSI-derived embryo sHLA-G expression on pregnancy and implantation rates: A prospective study. Hum Reprod 2005; 20: 1359.
29. Sher G, Keskintepe L, Fisch JD, et al. Soluble human leukocyte antigen G expression in phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertil Steril 2005; 83: 1410.
30. Rebmann V, Lemaoult J, Rouas-Freiss N, et al. Report of the wet workshop for quantification of soluble HLA-G in Essen, 2004. Hum Immunol 2005; 66: 853.
31. Creput C, Durrbach A, Samuel D, et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant 2003; 3: 348.
32. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigenpresenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001; 13: 385.
33. Ristich V, Liang S, Zhang W, et al. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005; 35: 1133.
34. Liang S, Horuzsko A. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 2003; 64: 1025.